CRNX — Crinetics Pharmaceuticals, Inc. stock price, charts and financials

QT61Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
83.86
+0.10+0.12%
OverviewShort InterestFilings
CRNXQT61Crinetics Pharmaceuticals, Inc.·NASDAQ
83.86+0.12%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 202610-QQuarterly report
Aug 03, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 03, 20268-KCurrent report
Jul 31, 2026DEFM14ADefinitive proxy statement (merger)
Jul 21, 2026PREM14APREM14A
Jul 10, 20268-KCurrent report
Jul 10, 2026DEFA14AAdditional proxy soliciting materials
Jul 07, 20264Statement of changes in beneficial ownership
Jul 06, 2026DEFA14AAdditional proxy soliciting materials
Jul 06, 2026DEFA14AAdditional proxy soliciting materials
Jul 06, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 20268-KCurrent report
#1 / 25 of 516
Page
▼
/ 21